BrosMed key facts
- Developer and manufacturer of medical devices designed to improve procedural outcomes for physicians and surgeons.
- Notable investors include Cowin Capital, IDG Capital, Mirae Asset Capital, YuanBio Venture Capital, Hillhouse Investment Group — 12 tracked in total.
- Status: In IPO Registration.
Who backs BrosMed
12+- ·The complete investor list: 12 names
- ·Watch BrosMed: the Monday email on marks, rounds and moves
BrosMed funding rounds
No funding rounds for BrosMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
BrosMed investors
12 investors are on record for BrosMed, including Cowin Capital, IDG Capital, Mirae Asset Capital and YuanBio Venture Capital. By type, the record holds 6 venture capital firms and 1 asset manager.
About BrosMed
Developer and manufacturer of medical devices designed to improve procedural outcomes for physicians and surgeons. The company's devices consist of interventional cardiovascular catheter series and endovascular catheter series which is used by cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimally invasive devices, enabling clinicians to expand treatment options for the patient freedom and fulfilment at a lesser cost.
- Sector
- Healthcare
- HQ
- Dongguan, China
- Founded
- 2012
- Employees
- 170
- Website
- brosmed.com/
- Ownership
- In IPO Registration
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
BrosMed doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.